Biomarkers and early detection of Alzheimer's
November 29, 2019
Dr. Mari DeMarco, Clinical Chemist at St. Paul's Hospital, was featured in the “Experimental drug would be first to reverse decline of Alzheimer's" article from Providence Health Care’s The Daily Scan.
The IMPACT-AD study (based at St. Paul’s Hospital and led by Dr. DeMarco) investigates how Alzheimer’s biomarker testing affects individuals and their families, medical decision-making and health care costs.
Click here to read the full article.